---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-030497"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2026-07-31T20:15:35+00:00"
generated_at: "2026-07-31T20:17:16.096989+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PDS Biotechnology receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received deficiency letter on July 30, 2026 for failing to meet minimum bid price of $1.00 for 30 consecutive business days.
- Has 180 calendar days, until January 26, 2027, to regain compliance with Nasdaq Listing Rule 5550(a)(2).
- Compliance can be regained if closing bid price is at least $1.00 for 10 consecutive business days during the period.
- Company may consider a reverse stock split to cure the deficiency; no assurance of regaining compliance.
- If not cured by deadline, stock may be delisted; company can appeal a delisting determination to a hearings panel.

## SEC filing metadata
- accession: 0001140361-26-030497
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2026-07-31T20:15:35+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036126030497/0001140361-26-030497-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126030497/ef20079199_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-030497
- JSON: https://secwatch.observer/filing/0001140361-26-030497.json
- Plain text: https://secwatch.observer/filing/0001140361-26-030497.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.